Cargando...
RARE-17. LENALIDOMIDE AS TREATMENT FOR RELAPSED OR REFRACTORY PRIMARY CNS LYMPHOMA: A SINGLE INSTITUTIONAL EXPERIENCE
BACKGROUND: Primary CNS Lymphoma (PCNSL) is an aggressive form of diffuse large B-cell lymphoma (DLBCL). Lenalidomide is an immunomodulatory agent which has shown activity in relapsed or refractory CNS and non-CNS DLBCL. The ideal dosing, timing as consolidation therapy, and role in maintenance ther...
Gardado en:
| Publicado en: | Neuro Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6217683/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.991 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|